Additional information
| Active substance | Arimistane | 
|---|---|
| Active Half-Life | 2-4 hours | 
| Classification | Aromatase Inhibitor | 
| Dosage | 50 mg/day | 
| Acne | No | 
| Water Retention | No | 
| HBR | No | 
| Hepatotoxicity | No | 
| Aromatization | No | 
| Lab Test | See Document | 
| Also known as | Arimistane | 
| WAREHOUSE | USA Warehouse 2 | 
| Blood pressure | Can potentially increase if water retention occurs | 
| Trade name | Not commercially available as a medication | 
| Storage conditions | Store in a cool, dry place away from light | 
| Chemical name | Androsta-3,5-diene-7,17-dione | 
| Formula | C19H24O2 | 
| Substance class | Steroidal aromatase inhibitor | 
| Main action | Inhibition of aromatase enzyme, reducing estrogen synthesis | 
| Half-life | 48 hours | 
| Dosage (medical) | Not typically used for medical purposes | 
| Dosage (sports) | 50-75 mg per day | 
| Effects | Increased testosterone levels, decreased estrogen levels | 
| Side effects | Potential hormonal imbalances, risk of joint discomfort, and potential impact on lipid profiles | 
| Use in sports | Used as an ancillary compound to manage estrogen levels in anabolic steroid cycles | 
| Manufacturer | Spectre Labs | 
 Tamoxifen 20 Aaster Health and Sports Solutions
							Tamoxifen 20 Aaster Health and Sports Solutions						 Proviron 25 Aaster Health and Sports Solutions
							Proviron 25 Aaster Health and Sports Solutions						

 
			 
			 
			 
			
Reviews
There are no reviews yet.